{"title": "Diabetes drug effective against heart failure in wide spectrum of patients", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/heart_disease.xml", "value": "Diabetes drug effective against heart failure in wide spectrum of patients"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190318121100.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190318121100.htm", "summary": "The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, a measure of the heart's pumping ability indicative of poor heart functioning, according to new research.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/heart_disease.xml", "value": "The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, a measure of the heart's pumping ability indicative of poor heart functioning, according to new research."}, "published": "Mon, 18 Mar 2019 12:11:00 EDT", "published_parsed": [2019, 3, 18, 16, 11, 0, 0, 77, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190318121100.htm", "guidislink": false}